Connect with us
Novo Nordisk, the Danish manufacturer of weight-loss drugs Ozempic and Wegovy, has a large market share in the US. But it's not enough to put pressure...
How weight loss demand is draining Europe’s diabetes drug supply, as countries adopt varying speeds of approach to medicinal approval for dual purposes.
Novo Nordisk announced launching a direct-to-patient online pharmacy NovoCare, offering a more than half-price cut for its weight-loss treatment Wegovy.
